# Blood Samples to Identify Biomarkers of Busulfan

> **NCT02291965** · — · TERMINATED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 139 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma
- Immunodeficiency
- Myelodysplastic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02291965
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2019-04-20
- **Final completion:** 2024-10-07
- **Target enrollment:** 139 (ACTUAL)
- **Why stopped:** Study terminated due to end of funding
- **Last updated:** 2025-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291965, "Blood Samples to Identify Biomarkers of Busulfan". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02291965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*